Inventiva IVA
NASDAQ IVA
$3.65 +0.36 (+10.96%)
As of: Sep 30, 2026 · 10:25 AM EDT

Inventiva (IVA) EBITDA Margin (2020 - 2021)

Updated

Inventiva (IVA) reported EBITDA Margin of -3073.61% for FY2025, down 2069.48 percentage points from -1004.13% in FY2024.

Analysis

Inventiva (IVA) EBITDA Margin (2020 - 2021) Analysis & Trends

Dating back to FY2018, Inventiva's EBITDA Margin record includes 8 years.

  • EBITDA Margin has declined for three consecutive years, though with a five-year change of +4407.57 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the lowest annual EBITDA Margin since FY2020.
  • According to Business Quant data, EBITDA Margin came in at -1004.13% in FY2024 (-431.32 pp), -572.81% in FY2023 (-117.83 pp), -454.98% in FY2022 (+818.32 pp) and -1273.30% in FY2021 (+6207.89 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 35.95%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 49.01%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 6.02%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 33.11%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 46.01%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -124.26%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 39.10%
10 Inventiva 682.13 Mn 682.13 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -20,667.69%
Mar 31, 2021 -13,024.32%
Jun 30, 2020 -11,527.03%
Mar 31, 2020 -7,434.48%
API Access

Inventiva EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IVA&period=max&api_key=YOUR_API_KEY